Discover the latest CEPI news
Keep up-to-date on the latest announcements and updates from CEPI and our global partners.
News
European Union and Singapore Back CEPI’s Plan to Boost Global Defences Against Epidemic and Pandemic Threats
Major new investments bolster global coalition's five-year plan to develop vaccines against the most dangerous pathogens and transform the world’s ability to tackle epidemic and pandemic threats.
Explainer
Bundibugyo Virus – What it is and what it is not
Blog
What the Hantavirus outbreak tells us about preparing for Disease X
Blog
Inside VIDO’s work to stay ahead of the next pandemic
Blog
CEPI 3.0 explained: Vaccines and viral families
Impact story
How a rapid-response bird flu vaccine trial is shaping global preparedness
News
CEPI and Pasteur Network partner to advance regional vaccine R&D and outbreak preparedness
News
CEPI and PAHO expand partnership to strengthen regulatory systems and vaccine safety across the Americas
Blog
Could our nose cells be key to preventing future pandemic spread?
News
R&D roadmaps for pathogen families to reduce uncertainty about the next pandemic
News
Global health leaders join CEPI’s Board and expert groups
Blog
Ronald Kakeeto: My Fellowship at CEPI
Blog
Dr Navneet Bichha: My Fellowship at CEPI
Blog
From ambition to action: Turning CEPI’s strategy into tangible impact
Blog
Dr Umar Ahmad: My Fellowship at CEPI
News
CEPI launches global plan to secure the future against epidemic and pandemic threats
News
Korea runs landmark pandemic simulation exercise to strengthen outbreak readiness
Blog
Strengthening biosecurity and biosafety oversight: CEPI publishes its first Biosecurity Policy
.webp)
News
CEPI and Korea discuss future of AI-driven international health cooperation
News
CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access
News
Preparing today for tomorrow’s Lassa fever vaccines
News
CEPI backs updated Zaire ebolavirus vaccine that aims to improve vaccine affordability and accessibility
News
CEPI, Oxford, Serum create largest-ever reserve of investigational Rift Valley fever vaccine
News
Ambitious research to develop multivalent vaccines against deadly filoviruses
News
CEPI calls for experts to join its Scientific Advisory Committee
.webp)
Blog
Reflections on 2025 – Richard Hatchett
.webp)
News
CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate
Blog
The pain after the bite: Tracking Chikungunya’s debilitating impact in East Africa
News
Sinergium paves the way for Latin American mRNA vaccines with new preclinical study
News
University of Oxford launches world’s first Phase II Nipah virus vaccine trial
Impact story
Closing in on protection against deadly Nipah virus
News
Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus
Blog
Disease outbreak survivors are key to future preparedness
News
First volunteer receives Lassa fever vaccine in cutting-edge Oxford trial
.webp)
News
Korea steps up pandemic response with $18.9m investment in CEPI
Blog
A blueprint for access at the heart of outbreak R&D
News
IAVI’s Lassa fever vaccine shows promise in early clinical trials
News
Progress towards regionalised vaccine manufacturing remains uneven
Blog
The ‘Big One’ is coming: How can we prepare for a future coronavirus pandemic?
.webp)
News
Global vaccine safety network to launch in six countries across three continents
News
